Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · IEX Real-Time Price · USD
6.01
-0.21 (-3.45%)
At close: Jul 19, 2024, 4:00 PM
6.32
+0.31 (5.16%)
Pre-market: Jul 22, 2024, 7:07 AM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $178.83 million as of July 22, 2024. Its market cap has increased by 402.34% in one year.
Market Cap
178.83M
Enterprise Value
173.94M
1-Year Change
402.34%
Ranking
Category
Stock Price
$6.01
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has decreased from $222.39M to $178.83M, a decrease of -19.58%. That is a compound annual growth rate of -7.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 178.80M | 320.71% |
| Dec 29, 2023 | 42.50M | -17.79% |
| Dec 30, 2022 | 51.70M | -76.96% |
| Dec 31, 2021 | 224.40M | 0.90% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Seres Therapeutics | 185.52M |
| OptimizeRx | 183.06M |
| XBiotech | 181.83M |
| Biomea Fusion | 181.16M |
| Ventyx Biosciences | 179.77M |
| Accuray | 178.64M |
| Metagenomi | 178.33M |
| Puma Biotechnology | 176.55M |